H-CYTE, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.09 million compared to USD 3.89 million a year ago. Basic loss per share from continuing operations was USD 3.38 compared to USD 23.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -33.33% | 0.00% | -82.76% |
1st Jan change | Capi. | |
---|---|---|
-82.76% | 107K | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- IVRN Stock
- News Innoveren Scientific Inc.
- H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023